Thank you for visiting the GIAPREZA (angiotensin II) website. The GIAPREZA website is designed to provide a general overview of GIAPREZA. The content and the website in general is not intended to be used for medical and/or clinical advice. Doctors or other health care providers that visit this site should not rely on any medical information contained within this website, and need to exercise their independent and professional judgment in treating patients. Also, the information contained in this website is not intended to be used in making any decision relating to an investment in securities of La Jolla. La Jolla makes no representations as to the accuracy or completeness of any information on this website or accessed through this website, and may alter or delete materials or links at any time.
While La Jolla takes precautions to make sure the information it provides on this website is accurate and complete, it expressly disclaims any warranty or representation regarding the information. THE INFORMATION ON THIS WEBSITE IS PROVIDED "AS IS," WITHOUT A WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. You agree that your use of this website is done at your own risk, and that La Jolla will not be liable for any damages of any kind resulting from your use of this website or reliance on information contained on this website.
The GIAPREZA website, and any content, trademarks and logos are either licensed from third parties or are the possession of La Jolla. Any content on the GIAPREZA website is protected by intellectual property rights, including trademark, copyright and patent, and may not be used without La Jolla’s express permission.
This website contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. We caution readers that forward-looking statements are based on management’s expectations and assumptions as of the date of this website and involve substantial risks and uncertainties that could cause the actual outcomes to differ materially from what we currently expect. These risks and uncertainties include, but are not limited to, those associated with: GIAPREZA™ (angiotensin II) sales; regulatory actions relating to La Jolla’s products by the U.S. Food and Drug Administration (FDA), European Commission and/or other regulatory authorities; cash used in operating activities and our capital requirements; and other risks and uncertainties identified in our filings with the U.S. Securities and Exchange Commission. Forward-looking statements in this website apply only as of the date made, and we undertake no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.
Your privacy and the privacy of all our users is important. Please review our Privacy Notice.
Any communication or material you transmit to La Jolla via the Site, other than personally identifiable information, will be treated by La Jolla as non-confidential and non-proprietary. Thus, in the absence of a written agreement with La Jolla to the contrary, you agree that you will not submit to La Jolla any information or ideas that you consider to be confidential or proprietary.
La Jolla may terminate your access to and use of the Site, at La Jolla’s sole discretion, at any time and without notice to you. Upon any termination, discontinuation or cancellation of the Site, all provisions of these Terms which by their nature should survive will survive, including, without limitation, ownership provisions, warranty disclaimers, limitations of liability, and dispute resolution provisions.
La Jolla Pharmaceutical Company
4747 Executive Drive, Suite 240
San Diego, CA 92121